Prophase Labs Stock Probability of Future Stock Price Finishing Over 24.23
| PRPH Stock | USD 0.75 0.01 1.35% |
ProPhase |
ProPhase Labs Target Price Odds to finish over 24.23
The tendency of ProPhase Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 24.23 or more in 90 days |
| 0.75 | 90 days | 24.23 | close to zero percent |
Based on a normal probability distribution, the odds of ProPhase Labs to move over $ 24.23 or more in 90 days from now is close to zero percent (This ProPhase Labs probability density function shows the probability of ProPhase Stock to fall within a particular range of prices over 90 days) . Probability of ProPhase Labs price to stay between its current price of $ 0.75 and $ 24.23 at the end of the 90-day period is about 98.0 .
Given the investment horizon of 90 days ProPhase Labs has a beta of -0.58 indicating as returns on the benchmark increase, returns on holding ProPhase Labs are expected to decrease at a much lower rate. During a bear market, however, ProPhase Labs is likely to outperform the market. Additionally ProPhase Labs has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. ProPhase Labs Price Density |
| Price |
Predictive Modules for ProPhase Labs
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ProPhase Labs. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ProPhase Labs Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. ProPhase Labs is not an exception. The market had few large corrections towards the ProPhase Labs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ProPhase Labs, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ProPhase Labs within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.5 | |
β | Beta against Dow Jones | -0.58 | |
σ | Overall volatility | 0.66 | |
Ir | Information ratio | -0.22 |
ProPhase Labs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ProPhase Labs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ProPhase Labs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| ProPhase Labs generated a negative expected return over the last 90 days | |
| ProPhase Labs has high historical volatility and very poor performance | |
| ProPhase Labs has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 44.38 M. Net Loss for the year was (16.78 M) with profit before overhead, payroll, taxes, and interest of 70.65 M. | |
| ProPhase Labs currently holds about 27.5 M in cash with (11.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: ProPhase Labs plummets 21, prices 3M equity offering - MSN |
ProPhase Labs Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ProPhase Stock often depends not only on the future outlook of the current and potential ProPhase Labs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ProPhase Labs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 17.2 M | |
| Cash And Short Term Investments | 4.7 M |
ProPhase Labs Technical Analysis
ProPhase Labs' future price can be derived by breaking down and analyzing its technical indicators over time. ProPhase Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ProPhase Labs. In general, you should focus on analyzing ProPhase Stock price patterns and their correlations with different microeconomic environments and drivers.
ProPhase Labs Predictive Forecast Models
ProPhase Labs' time-series forecasting models is one of many ProPhase Labs' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary ProPhase Labs' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about ProPhase Labs
Checking the ongoing alerts about ProPhase Labs for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ProPhase Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| ProPhase Labs generated a negative expected return over the last 90 days | |
| ProPhase Labs has high historical volatility and very poor performance | |
| ProPhase Labs has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 44.38 M. Net Loss for the year was (16.78 M) with profit before overhead, payroll, taxes, and interest of 70.65 M. | |
| ProPhase Labs currently holds about 27.5 M in cash with (11.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: ProPhase Labs plummets 21, prices 3M equity offering - MSN |
Check out ProPhase Labs Backtesting, ProPhase Labs Valuation, ProPhase Labs Correlation, ProPhase Labs Hype Analysis, ProPhase Labs Volatility, ProPhase Labs History as well as ProPhase Labs Performance. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (1.53) | Revenue Per Share 0.996 | Quarterly Revenue Growth (0.81) | Return On Assets (0.23) |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.